Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2880 (LINC02880) is a gene located on chromosome 6q21 in humans that encodes for a long non-coding RNA transcript of the lincRNA subclass. LincRNAs are defined as autonomously transcribed RNAs longer than 200 nucleotides that do not overlap coding genes, and they often act as regulators of gene expression by scaffolding chromatin-modifying complexes or participating in post-transcriptional regulation. There is no current evidence that LINC02880 serves as a direct drug target, biomarker, or has a specifically described role in disease. Its aliases include the gene synonym FLJ34503. Overall, while lincRNAs are a fundamental part of the non-coding genome with wide regulatory roles, LINC02880 has not been characterized sufficiently to be considered a canonical therapeutic target or be linked to a specific biological function or disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2880 (LINC02880).